Lucile Noyer

Postdoc studying ion channels and transporters in immunology and cancer @Feskelab @nyulangone 2022 ASH Scholar Award

[Lucile Noyer @NoyerLucile]

I’m excited to share our new paper published in @SciImmunology ! Together with @Liwei_K, we show that CLNS1A is essential for T cells and autoimmunity.
1/3
https://t.co/XIv0qADWGt

[Journal of Human Immunity @jhumimmunity]

Noyer et al. @Feskelab show that a novel mutation in ORAI1 results in constitutive CRAC channel activation while abolishing stimulation-induced channel opening. The mutation is associated with severe immune dysregulation, incl. altered T & NK cell function https://t.co/egJQM1FRgs

[Waggoner Lab @LabWaggoner]

CLNS1A promotes autoimmunity through epigenetic and transcriptional regulation of DNA repair and cell cycle progression in CD4 T cells @SciImmunology @NoyerLucile @St_Feske
https://t.co/8reoCQXYFC

[Science Immunology @SciImmunology]

New research from @Feskelab suggests that chloride nucleotide-sensitive channel 1A (CLNS1A) is a key transcriptional and epigenetic regulator of pathogenic #CD4 #Tcells in mouse models of #autoimmune and inflammatory diseases. https://t.co/Wn6mRdDgvN

[Lucile Noyer @NoyerLucile]

Thank you to the best co-first @Liwei_K, @Feskelab, and all the co-authors that made this happen! @nyugrossman

[Lucile Noyer @NoyerLucile]

I’m excited to share our new paper published in @SciImmunology ! Together with @Liwei_K, we show that CLNS1A is essential for T cells and autoimmunity.
1/3
https://t.co/XIv0qADWGt

[Lucile Noyer @NoyerLucile]

We dive into the role of CLNS1A (chloride nucleotide sensitive channel 1a) in T cells. Surprisingly, it does not regulate chloride currents in T cells. We show that CLNS1A interacts with PRMT5, functions as an essential epigenetic regulator of DNA damage response machinerie.
2/3

[Feske lab at NYU @Feskelab]

The Feske Lab is on fire at the Channels and Transporters in Immunity FASEB conference! #CTISRC #FASEBconference #ICTImmunityConference

[SantanaCodina lab @SantanaCodina]

Extended call: 3 more weeks to apply for a postdoc position in our lab focused on the role of iron in pancreatic cancer and drug resistance. DM for any questions.

https://t.co/lnVkNn1lEL

[NYU GSOM Pathology @NYUGSOM_Path]

Join the IonLab electrophysiology core facility at NYU Langone Health as a Research Associate! Contribute to innovative research on ion channels in health and disease. Apply now at https://t.co/nLb6NF6hRR #ResearchAssociate #Pathology #IonLab #Electrophysiology

[Lucile Noyer @NoyerLucile]

Very grateful for this award to @Feskelab and excited to continue investigating the role of ORAI2 in melanoma together with #twitterless Liwei Wang!

[Melanoma Research @MelanomaReAlli]

Congratulations to Stefan Feske M.D. of New York University Grossman School of Medicine on receiving an MRA Established Investigator Award to study "Mechanisms underlying the oncogenic role of ORAI2 in melanoma"! @nyugrossman #melanoma #research

[Lucile Noyer @NoyerLucile]

@pedrosvdr @NortheasternCOS @Northeastern Congrats 🥳🥳🥳

[Trebak Lab @TrebakM]

Synergy between Orai1 and Orai3 calcium signaling in mediating B lymphocyte metabolic reprogramming in response to BCR activation. Thanks to our wonderful collaborators, Zia Rahman (Penn State) and @Feskelab (NYU). https://t.co/Wra56ZvFdS

[Iannis Aifantis @iannisaifantis1]

A tenure-track faculty position in Immunology is available @NYUGSOM_Path . Applicants should pursue innovative research with direct application to human immunology. Come and join us in New York City! #Immunology #ScienceTwitter
https://t.co/nAX7iNzPSw

[Waggoner Lab @LabWaggoner]

Initial time-of-day of tumor engraftment dictates ensuing tumor size across murine cancer models. Rhythmic trafficking of DCs to dLN governs circadian response antitumor CD8+ T cells via CD80.
https://t.co/HM6RfBYwtu

[Matthew D. Park, PhD @MatthewD_Park]

I'm very excited to share a review written together with @AymericSilvin @FGinhoux @MiriamMerad in @CellCellPress on macs in health & disease. We share our thoughts on how the field should approach the study of macs & on the field's now pressing questions! https://t.co/PAXvLLMkgb

[Mikala Egeblad @megeblad]

My fellows are getting jobs. Great, except my lab is shrinking! We will be looking for postdocs to join us in studying how the tumor immune microenvironment (incl. neutrophils) & systemic changes (incl. those caused by stress) control metastasis. Email me: [email protected]

[Immunology of Infectious Disease News @infdisease_news]

T cell-specific deletion of Orai1 did not exacerbate pulmonary inflammation 🔥 and viral burdens following IAV infection, but protected mice from house #DustMite–induced allergic airway inflammation.

🖊️ By Dr. Stefan Feske at @nyugrossman and team.

📂 https://t.co/Z9c8eZy20Q

[Amanda Lund Lab @theLundLab]

We are looking for postdocs/scientists to work on multiple funded projects exploring lymphatic transport, T cell trafficking, and lymph node biology! Check us out, shoot me an email, or find me at the Lymphatics Gordon in Tuscany and #SITC22 in Boston! https://t.co/k8qceaUW85

[Feske lab at NYU @Feskelab]

Please join us for the first #ICTI free webinar held by @Michael_Cahalan about Ion Channels and Calcium Signaling in T cells. Find out more at https://t.co/cybYsCqpR2

[Axel R. Concepcion @AxelRConcepcio1]

📣We are one day away to kick in the first ever webinar of the Ion Channels & Transporters in Immunity seminar series!
Wednesday, October 19th, 2022
11am ET
More info: https://t.co/H5pQ8yxRSe
Please share!!! #ionchannels #immunity
Zoom link: https://t.co/i2Ukh1kIwE